NCT02068092

Olive Oil for High Risk Breast Cancer Prevention in Women

A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: The Methodist Hospital Research Institute · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a pilot study evaluating the effect of hydroxytyrosol, a component of olive oil, on mammographic density in women at high risk of developing breast cancer.

Detailed description

This is a pilot study evaluating the effect of hydroxytyrosol, a component of olive oil, on mammographic density in women at high risk of developing breast cancer. Participants will take hydroxytyrosol orally once daily for 1 year. Breast density as determined by mammography and the safety/toxicity of hydroxytyrosol will be assessed.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
DRUG	Hydroxytyrosol

Timeline

• Start date: 2013-12-01
• Primary completion: 2021-07-01
• Completion: 2021-07-01
• First posted: 2014-02-21
• Last updated: 2023-10-10
• Results posted: 2023-10-10

Locations

3 sites across 1 country: United States

Regulatory

• FDA-regulated drug study